Anti-CERT antibody and 3 more items

Epitomics Inc. has been awarded a purchase order (A207_PO-0460414) by the University of Virginia to provide four specialized antibody products for research purposes. The contract, awarded on July 21, 2026, carries a cumulative value of $1,864.00. The deliverables consist of four distinct monoclonal antibodies: Anti-CERT antibody ($440.00), Anti-STAT5a phospho Y694 antibody ($416.00), Anti-STAT5b phospho S731 antibody ($432.00), and Anti-STAT5b antibody EPR16671 ($576.00). All materials are to be delivered to Angana Mainali at the University of Virginia's location in Virginia.

The purchase order represents a straightforward procurement of research-grade antibodies for use in scientific investigation or diagnostic applications. Each antibody is ordered in a quantity of one unit at individually specified unit prices. Given the research focus of the contracting organization and the nature of the products—which target signal transducer and activator of transcription (STAT) proteins and related cellular markers—this contract supports the University of Virginia's laboratory operations and research initiatives. The relatively modest contract value reflects a limited-scope materials purchase rather than a comprehensive service delivery engagement.